feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / Sun Pharma Stock Surges: Bullish Reversal Ahead?

Sun Pharma Stock Surges: Bullish Reversal Ahead?

2 Dec, 2025

•

Summary

  • Sun Pharma stock broke a year-long downtrend and descending triangle.
  • Increased trading volumes support the bullish stock reversal.
  • Experts predict a potential rise towards Rs 2000.
Sun Pharma Stock Surges: Bullish Reversal Ahead?

Sun Pharma's stock has demonstrated a significant bullish reversal, successfully breaking its year-long downtrend and a descending triangle chart pattern. This technical breakout, occurring after a substantial fall from recent highs, indicates a potential for a considerable upward movement.

The stock's performance is further bolstered by increasing trading volumes and its sustained position above critical moving averages. This combination of factors has led experts to predict a strong upward trend in the near future.

Traders and investors are advised to monitor the Rs 1750 support level closely. Experts suggest that the stock has the potential to ascend towards the Rs 2000 mark within the next few months, presenting a compelling scenario for market participants.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Sun Pharma's stock has shown a strong rebound, breaking a year-long downtrend and a descending triangle pattern.
Experts suggest Sun Pharma's stock could reach Rs 2000 in the coming months.
Traders are advised to watch the Rs 1750 support level for Sun Pharma stock.

Read more news on

Business and Economyside-arrow
trending

Chelsea beats West Ham 3-2

trending

Liverpool, Newcastle face injury woes

trending

WWE Royal Rumble in Riyadh

trending

Barcelona faces Elche in LaLiga

trending

Goretzka staying at Bayern Munich

trending

ICC T20 World Cup squads

trending

Gold, silver ETFs crashed

trending

Curran, Pandya T20Is stats compared

trending

Suryakumar Yadav T20I record

You may also like

Sun Pharma Q3 Profits Soar 16% on Strong Revenue Growth

1 day ago • 6 reads

article image

Ajanta Pharma Sees Sales Surge 20%, Profit Jumps 18%

30 Jan • 3 reads

article image

Sun Pharma Eyes $10B Women's Health Buyout

19 Jan • 68 reads

article image

Pharma Index Slides: Ajanta Pharma Climbs Amidst Drop

24 Dec, 2025 • 148 reads

article image

Indian Pharma Shifts Gears: Beyond US Generics

7 Dec, 2025 • 293 reads

article image